Why Pharma Content Strategies Fail at Scale
The failure of a pharma content strategy at scale has one simple reason: the volume of assets scaled by a team before the system planning, reviewing, localizing, distributing, and measuring assets scales with that asset volume. In biopharma, such a divide manifests itself quickly. Field teams consume less than half the content in less than…
Anthony Wildeno